Evidence map›Paper›PMID 38616936›Full record

ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2024

Refined balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension - reference center experience.

Andrzej Łabyk, Marcin Krakowian, Łukasz Mysiorski, Barbara Lichodziejewska, Olga Dzikowska-Diduch, Aisha Ou-Pokrzewińska, Dariusz Zieliński, Marek Gołębiowski, Piotr Pruszczyk, Marek Roik

Abstract read
In one paragraph

Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Dicrotic notch index in pulmonary hypertension: correlation with hemodynamic, echocardiographic and clinical parameters.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrzej ŁabykDepartment of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.
Marcin KrakowianDepartment of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.
Łukasz MysiorskiDepartment of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.
Barbara LichodziejewskaDepartment of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.
Olga Dzikowska-DiduchDepartment of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.
Aisha Ou-PokrzewińskaDepartment of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.
Dariusz ZielińskiDepartment of Cardiac Surgery, Medicover Hospital, Warsaw, Poland.
Marek Gołębiowski1 Department of Radiology, Medical University of Warsaw, Infant Jesus Teaching Hospital Warsaw, Warsaw, Poland.
Piotr PruszczykDepartment of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.
Marek RoikDepartment of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH), characterized by thromboembolic changes affecting the pulmonary bed, leads to ventricular function deterioration and premature death. The introduction of balloon pulmonary angioplasty (BPA) has significantly improved the prognosis of CTEPH patients. Aim: The authors of this article decided to summarize the experience of the BPA program, conducted between 2014 and 2022, at the reference center. Material and methods: Among 111 CTEPH patients, 55 were included in the analysis. A total of 226 sessions were performed, with a significant percentage of intravascular imaging and pressure catheter use. Results: Mean pulmonary pressure decreased significantly from 42 (22-66) to 26.5 mm Hg (11-54) ( Conclusions: BPA programs conducted in experienced centers are a safe and effective treatment option for inoperable CTEPH patients.

Indexed as

balloon pulmonary angioplastychronic thromboembolic pulmonary hypertensionpercutaneous

Identifiers

PMID38616936
PMCPMC11008523

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.